The Centers for Medicare & Medicaid Services (CMS) has finalized major changes to Medicare hospital outpatient payments for 2027, introducing new reimbursement rates and policies that could affect hospitals, healthcare providers and patients across the United States.

Under the new rule, Medicare outpatient payment rates will increase by 2.3% in 2027 for hospitals meeting applicable quality-reporting requirements. However, the policy also introduces changes to reimbursement for medicines purchased through the federal 340B drug discount programme.

CMS will set Medicare payments for separately payable 340B drugs at the average sales price minus 28%. The agency says the changes are intended to adjust drug payments and reduce certain healthcare costs.

The rule also expands site-neutral payments to certain imaging services performed in qualifying off-campus hospital outpatient departments. CMS estimates this provision could reduce Medicare Part B spending by approximately $260 million in its first year.

Additionally, CMS will remove 637 more procedures from its inpatient-only list, potentially allowing eligible patients to receive those services in outpatient settings when clinically appropriate.

Hospital associations have raised concerns about the financial impact, particularly on teaching hospitals and providers serving vulnerable communities.

The changes are scheduled to take effect in 2027 and could reshape Medicare reimbursement, hospital finances and outpatient care delivery.